In psoriasis treatment, luteolin has shown strong anti-inflammatory properties in keratinocytes by inhibiting TNF-α-induced production of inflammatory mediators, including IL-6, IL-8, and VEGF. The gene discussed is TNF; the disease is psoriasis.